Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
暂无分享，去创建一个
M. Post | P. Kligfield | P. Okin | R. Crystal | R. Devereux | M. Parikh | N. Hackett | Leonard Y. Lee | R. Hachamovitch | M. Lesser | T. Sanborn | R. Hahn | M. Szulc | T. Rosengart | O. Isom | G. Bergman | R. Hahn | S. Patel | P. Okin | M. Post | L. Lee | M. Parikh | R. B. Devereux | Shailen R. Patel | T. M. Grasso | T. Foster | S. Patel | G. W. Bergman | Taliba Foster | T. Grasso | Martin L. Lesser | M. Lesser | Rebecca T. Hahn